Simultaneous assessment of muscle perfusion and mitochondrial function in ME/CFS
Fördersumme: € 40.000
Mechanism-based Reversibility Evaluation and Stratified Endophenotyping of Treatment-response in ME/CFS
Dauer: 36 Monate, Fördersumme: € 999.930
Effects of metyrapone treatment on cardio-metabolic risk and chronobiology in patients with mild autonomous cortisol secretion
Dauer: 48 Monate, Fördersumme: € 997.688
Decoding GNB1E: Advanced Drug Repurposing for Personalized Treatment
Dauer: 48 Monate, Fördersumme: € 999.979
Unraveling Host Glycobiology-Microbiome Interactions to Inform Precision Approaches in Colorectal Cancer
Dauer: 48 Monate, Fördersumme: € 998.582
The role of the skeletal muscle and myocardial metabolism in ME/CFS: in vivo MRS study.
Dauer: 19 Monate, Fördersumme: € 99.982